Abstract-Vascular senescence is closely associated with age-related vascular disorders and is enhanced by angiotensin (Ang) II type 1 receptor stimulation. However, the role of Ang II type 2 receptor activation in vascular senescence is still an enigma. Ang II stimulation significantly increased senescence-associated ␤-galactosidase activity and the level of 8-hydroxy-2Ј-deoxyguanosine, with enhancement of oxidative stress and expression of Ki-ras2A, p53, and p21 in vascular smooth muscle cells (VSMCs) from wild-type (Agtr2 ϩ ) mice, whereas these effects of Ang II were enhanced in VSMCs from Ang II type 2 receptor null (Agtr2 Ϫ ) mice. Administration of an Ang II type 1 receptor blocker, valsartan, attenuated these parameters, with less effect in Agtr2 Ϫ VSMCs. Ang II stimulation increased methyl methanesulfonate sensitive 2 (MMS2) expression in Agtr2 ϩ VSMCs but not in Agtr2 Ϫ VSMCs. MMS2 small-interfering RNA treatment enhanced Ang II-induced senescence-associated ␤-galactosidase activity and 8-hydroxy-2Ј-deoxyguanosine level with no significant changes in oxidative stress markers and the expression of Ki-ras2A, p53, and p21. Moreover, exposure of Agtr2 ϩ VSMCs to hydrogen peroxide and ultraviolet irradiation induced marked increases in senescence-associated ␤-galactosidase activity and 8-hydroxy-2Ј-deoxyguanosine level, which were further enhanced in Agtr2
V ascular senescence plays an important role in agerelated vascular disorders. 1 Angiotensin (Ang) II type 1 (AT 1 ) receptor stimulation has recently been suggested to provoke vascular cell senescence. 2 Treatment with AT 1 receptor blockers (ARBs) showed protective effects on ageassociated vascular diseases. 3 Moreover, some articles and our study indicated that oxidative stress, Ki-ras2A (a member of the oncoprotein Ras family) and its downstream target (cell cycle transcriptional activator), p53/cyclin-dependent kinase inhibitor, and p21 pathway are involved in the senescencepromoting effect of the AT 1 receptor. 2, 4, 5 In contrast, the roles of activation of the Ang II type 2 (AT 2 ) receptor in vascular senescence are totally unknown. AT 2 receptor expression is reported to be upregulated in cardiac senescence, 6 and AT 2 receptor stimulation is believed to be oppose AT 1 receptor-mediated signaling and functions. 7 Moreover, AT 2 receptor stimulation has a unique mechanism in addition to a negative interaction with AT 1 receptor signaling. 8 -10 Therefore, it is possible that AT 2 receptor activation could prevent vascular senescence via both inhibition of AT 1 receptor-mediated signaling and its own signaling mechanism. Recently, many genetic studies supported the important role of DNA repair in the protection of damaged DNA and the prevention of cellular senescence. 11 Methyl methanesulfonate sensitive 2 (MMS2), a family of ubiquitin-conjugating enzyme variants, could act as a key factor for DNA repair. 12 Moreover, we demonstrated previously that AT 2 receptor stimulation induces MMS2 expression, resulting in DNA repair and neural differentiation. 9, 13 These findings led to a hypothesis that AT 2 receptor signaling could prevent vascular senescence through Ն2 mechanisms: an MMS2-mediated protection system for DNA damage and counteracting the AT 1 receptor-mediated signaling pathway.
Methods
This study was performed in accordance with the National Institutes of Health guidelines for the use of male wild-type (Agtr2 ϩ ) mice (C57BL/6J; Clea Japan, Inc, Osaka, Japan) and AT 2 receptor null (Agtr2 Ϫ ) mice (based on the C57BL/6J strain bred in our laboratory). Vascular smooth muscle cells (VSMCs) were isolated from the thoracic aorta of Agtr2 ϩ mice and Agtr2 Ϫ mice by the explant method. Ang II or other reagents were administrated to VSMCs as described previously. 4 VSMCs were subjected to repeated 250 mJ/cm 2 UV irradiation and 2 hours of 600 mol/L of hydrogen peroxide (H 2 O 2 ) exposure. The irradiated mouse model was performed by 10 Gy of total-body x-ray irradiation before and after valsartan administration. Senescence-associated ␤-galactosidase (SA-␤-gal) activity was measured using a Senescence Detection kit. Immunoblot analysis and RNA interference of MMS2 were performed as described previously. 4 Activity of nicotinamide-adenine dinucleotide phosphate oxidase in VSMCs was measured by a luminescence assay, and superoxide generation was determined by lucigenin chemiluminescence. Quantification of 8-hydroxy-2Ј-deoxyguanosine (8-OHdG), a DNA damage marker, was performed by an ELISA. An expanded Methods section is available in the data supplement (available online at http://hyper.ahajournals.org).
Results

Deletion of AT 2 Receptor Signaling Enhanced Vascular Senescence and DNA Damage
Ang II (10 Ϫ7 mol/L) stimulation and 10-Gy x-ray irradiation induced a significant increase in SA-␤-gal activity in VSMCs and in the aorta prepared from Agtr2 ϩ mice, respectively, whereas this effect of Ang II or x-ray irradiation was exaggerated in VSMCs or in the aorta prepared from Agtr2 Ϫ mice ( Figure 1A and 1B and Figure S1A ). Moreover, 5 days of the addition of valsartan (10 Ϫ5 mol/L), a selective AT 1 receptor blocker, after 5 days of Ang II treatment decreased Ang II-induced SA-␤-gal activity in Agtr2 ϩ VSMCs, whereas this inhibitory effect of valsartan was weaker in Agtr2 Ϫ VSMCs. PD123319 (10 Ϫ5 mol/L), a specific AT 2 receptor blocker, treatment for 5 days increased Ang IIinduced SA-␤-gal activity in Agtr2 ϩ VSMCs to near the amount of Agtr2 Ϫ VSMCs ( Figure 1A) . Similarly, administration of valsartan (3 mg/kg per day) to Agtr2 ϩ mice decreased x-ray irradiation-induced SA-␤-gal activity in the aorta, and this inhibitory effect of valsartan was weaker in Agtr2 Ϫ mice ( Figure 1B ). These results suggest that deletion of AT 2 receptor signaling could enhance vascular senescence. 8-OHdG level, which is a biomarker of oxidative DNA damage, was similar to SA-␤-gal activity ( Figure S1B and S1C). We examined Ang II receptor expression and observed that AT 1 receptor expression in VSMCs and in the aorta of Agtr2 ϩ mice was not changed by Ang II stimulation ( Figure  S1D ) and x-ray irradiation (data not shown), respectively, whereas AT 2 receptor expression was increased by Ang II stimulation or x-ray irradiation and was further enhanced by valsartan treatment.
Deletion of AT 2 Receptor Signaling Increased Oxidative Stress and the Ki-ras2A-p53-p21 Pathway
We examined the inhibitory effect of AT 2 receptor signaling on AT 1 receptor-mediated oxidative stress and the Ki-ras2A/ p53/p21 pathway. Ang II-induced superoxide production and nicotinamide-adenine dinucleotide phosphate oxidase activity in VSMCs (Figure 2A and Figure S2 ) and x-ray irradiationinduced expression of p47 phox and Rac-1 in the aorta (data not shown) were exaggerated in Agtr2 Ϫ mice, respectively. Ang II stimulation markedly increased Ki-ras2A expression time dependently in Agtr2 ϩ VSMCs, as we reported previously in rat VSMCs, 4 and these effects of Ang II were enhanced in Agtr2 Ϫ VSMCs ( Figure 2B ). X-ray irradiation also caused an increase in Ki-ras2A expression in the aorta of Agtr2 ϩ mice, which was further enhanced in Agtr2 Ϫ mice ( Figure 2C ). Ang II stimulation also remarkably increased p53 and p21 expression time dependently in Agtr2 Ϫ VSMCs more than in Agtr2 ϩ VSMCs ( Figure 2D ). Moreover, the inhibitory effects of valsartan on these oxidative stress markers, Ki-ras2A, p53, and p21 expression in VSMCs or in the aorta were weaker in Agtr2 Ϫ mice than in Agtr2 ϩ mice (Figure 2A through 2D ).
Inhibition of AT 2 Receptor-Mediated MMS2 Associated With Enhancement of Vascular Senescence and DNA Damage
Ang II stimulation and x-ray irradiation significantly enhanced MMS2 expression in VSMCs and in the aorta of Agtr2 ϩ mice, respectively; the addition of valsartan further increased, and treatment with PD123319 attenuated this Ang II or the irradiation effect ( Figure S3A and S3B) . In contrast, an Ang II-mediated increase in MMS2 expression was not observed in Agtr2 Ϫ VSMCs ( Figure S3A) , and x-ray irradiation-induced MMS2 expression in the aorta was attenuated in Agtr2 Ϫ mice ( Figure S3B ). We chose H 2 O 2 or UV irradiation as DNA damage and senescence-inducing factors to further explore the role of MMS2 and observed that the MMS2 level was markedly increased in Agtr2 ϩ VSMCs after exposure to H 2 O 2 (600 mol/L) or UV irradiation (250 mJ/cm 2 ), whereas this effect of H 2 O 2 or UV irradiation was attenuated in Agtr2 Ϫ VSMCs ( Figure S3C ).
We used the RNA interference method to investigate the effect of MMS2 on SA-␤-gal activity and the 8-OHdG level. Under treatment with MMS2 small-interfering RNA (siRNA), the stimulatory effects of Ang II on SA-␤-gal activity and 8-OHdG level in Agtr2 ϩ VSMCs after 5 days of Ang II treatment were significantly increased compared with those under control-siRNA treatment ( Figures 3A and S3D ). SA-␤-gal activity and the 8-OHdG level were also significantly increased in control-siRNA-treated Agtr2 ϩ VSMCs after exposure to H 2 O 2 or UV irradiation, and they were further enhanced in control-siRNA-treated Agtr2
Ϫ and MMS2-siRNA-treated Agtr2 ϩ VSMCs. Moreover, SA-␤-gal activity and 8-OHdG level induced by H 2 O 2 or UV irradiation were higher in MMS2-siRNA-treated Agtr2 Ϫ VSMCs than in control-siRNA-treated Agtr2 Ϫ and MMS2-siRNA-treated Agtr2 ϩ VSMCs ( Figures 3B and S3E ).
Effect of MMS2 on Oxidative Stress and the Ki-ras2A-p53-p21 Pathway
Finally, we examined the association of MMS2 with oxidative stress and the Ki-ras2A-p53-p21 cascade and observed that MMS2-siRNA treatment did not significantly influence the Ang II-induced superoxide production; nicotinamideadenine dinucleotide phosphate oxidase activity; and Kiras2A, p53, and p21 expression on day 5 compared with those in control-siRNA-treated Agtr2 ϩ VSMCs ( Figure 4A through 4C and Figure S4 ).
Discussion
Vascular senescence mediated by AT 1 receptor stimulation has been highlighted, 2 and ARBs have been shown to prevent vascular disorders associated with aging. 3, 14 It has been reported that AT 1 receptor blockade and stimulation of unbound AT 2 receptors by Ang II could contribute to vaso- 
Min et al Role of AT 2 Receptor in Vascular Senescence
protective effects of ARBs, such as inhibition of vascular remodeling and atherosclerosis. 15, 16 However, the roles of AT 2 receptor stimulation in vascular senescence are not well investigated, leading us to examine the possibility that AT 2 receptor signaling could prevent vascular senescence and its possible mechanisms. We demonstrated that vascular senescence evaluated by SA-␤-gal activity was more exaggerated in Agtr2 Ϫ mice than in Agtr2 ϩ mice and that treatment with an ARB, valsartan, prevented vascular senescence, whereas this protective effect of valsartan was weaker in Agtr2 Ϫ mice in vitro and in vivo. We observed that AT 2 receptor expression was upregulated in senescent vascular cells of Agtr2 ϩ mice. These results indicate that AT 2 receptor signaling could play an important role in attenuating vascular senescence.
Oxidative stress and the oncoprotein Ras, which are essential for various signaling pathways, have been shown recently to trigger cellular senescence by regulating the level of the cyclin-dependent kinase inhibitor. 5, [17] [18] [19] We have demonstrated that AT 1 receptor-mediated oxidative stress enhances the Ki-ras2A-p53-cyclin-dependent kinase inhibitor p21 pathway, resulting in VSMC senescence. 4 In the present study, we addressed the issue that AT 2 receptor signaling prevented vascular cell senescence possibly because of its inhibitory effect on the AT 1 receptor-mediated signaling pathway. We demonstrated that oxidative stress; Ki-ras2A, p53, and p21 expression induced by Ang II stimulation; and x-ray irradiation were further enhanced in VSMCs and the aorta in Agtr2 Ϫ mice compared with those in Agtr2 ϩ mice. Therefore, we assumed a possible antagonistic effect of AT 2 receptor signaling on AT 1 receptor-mediated oxidative stress and the Ki-ras2A-p53-p21 signaling pathway could prevent vascular cell senescence. Although the detailed signaling mechanism of the antagonism of the AT 1 receptor by the AT 2 receptor is still poorly understood, AT 2 receptor stimulation is known to activate a variety of phosphatases and to enhance NO production in VSMCs. 20 Protein phosphatases could inactivate Ras-mediated signaling, such as mitogen-activated protein kinase, in response to mechanical stress. 21 Therefore, the direct downstream targets of Ki-ras2A, such as extracellular signal regulated kinase, p38 mitogen-activated protein kinase, or phosphatidylinositol 3-kinase, may also play potential roles in AT 2 receptor-mediated inhibition of vascular senescence.
Accumulation of a variety of DNA damage induced by environmental stress has been identified recently as a major Control-siRNA MMS2-siRNA factor in the progression of premature cell senescence. 22, 23 DNA repair systems are important in the prevention of cellular senescence induced by damaged DNA, 11 and it is suggested that aging of neurons is characterized by a general reduction in DNA repair capacity. 24 Therefore, the balance between accumulation of DNA damage and alterations in DNA repair processes could play an essential role in determining the onset and progress of senescence. We chose H 2 O 2 , UV irradiation, and x-ray irradiation as DNA damage and senescence-inducing factors to examine the possibility that AT 2 receptor signaling inhibits vascular cell senescence at least because of the attenuation of DNA damage. We demonstrated that the increases of 8-OHdG induced by Ang II administration, H 2 O 2 exposure, UV irradiation, and x-ray irradiation were greater in VSMCs and the aorta in Agtr2 Ϫ mice than in Agtr2 ϩ mice. Our findings suggested that AT 2 receptor signaling could prevent accumulation of DNA damage, contributing to the consequent attenuation of vascular senescence. Recently, it was suggested that oxidative DNA damage dependent on telomere shorting might be involved in AT 1 receptor-mediated replicative senescence. 25 Therefore, we need to further study the role of AT 2 receptor signaling in telomere shorting.
We explored the mechanism involved in the protection of DNA damage by AT 2 receptor signaling. MMS2, a family of ubiquitin-conjugating enzyme variants, was recently suggested to induce DNA repair on DNA damage via multiple pathways in neuronal development and differentiation. 12, 26 We have reported that AT 2 receptor stimulation could enhance MMS2 expression contributing to DNA repair and neural differentiation. 9,13 Therefore, we speculated that MMS2 might be involved in DNA repair and AT 2 receptorinhibited VSMC senescence. We observed that MMS2 expression was enhanced by Ang II stimulation and x-ray irradiation in VSMCs and in the aorta of Agtr2 ϩ mice, respectively, which was further increased by valsartan treatment. However, the Ang II-mediated increase in MMS2 expression was not observed in Agtr2 Ϫ VSMCs. Moreover, using MMS2-siRNA, we indicated that deletion of AT 2 receptor signaling inhibits MMS2 expression, resulting in enhancement of DNA damage and vascular senescence by AT 1 receptor stimulation. We also demonstrated the large increases in the MMS2 level in response to H 2 O 2 exposure, UV radiation, and x-ray irradiation in Agtr2 ϩ mice, but the small increases in Agtr2 Ϫ mice, leading us to assume that the increase in MMS2 could be a compensatory mechanism against DNA damage, and AT 2 receptor signaling could be important for the induction of MMS2 expression and protection of DNA damage in multiple conditions, although other possible pathways than AT 2 receptor signaling could directly upregulate MMS2. 27 Our recent study pointed out that a unique mechanism of the AT 2 receptor signaling involving MMS2 transactivation prevents neural damage. 9 Accordingly, in this study, we demonstrated that MMS2-siRNA treatment has no significant effects on Ang II-induced oxidative stress, and also Ki-ras2A, p53, and p21 expression in Agtr2 ϩ VSMC, suggesting that the MMS2 cascade may not be involved in the antagonistic effect of the AT 2 receptor against AT 1 receptor-mediated oxidative stress and the Ki-ras2A-p53-p21 pathway. Our findings support the idea that AT 2 receptor-mediated antisenescence signaling is closely related to an MMS2-dependent protection system for DNA damage, such as DNA repair, in addition to antagonizing AT 1 receptor signaling, and that the MMS2 cascade is an unique mechanism of AT 2 receptor signaling. The signaling cascade from AT 2 receptor stimulation to MMS2 activation and the detailed mechanism of MMS2 in mediating DNA repair and consequent inhibition of vascular senescence need to be further investigated.
Perspectives
Collectively, our findings suggest that AT 2 receptor signaling exerts inhibitory effects on vascular senescence through an MMS2-dependent protection system for DNA damage, such as DNA repair, as well as counteracting AT 1 receptormediated oxidative stress and the Ki-ras2A-p53-p21 pathway. We also demonstrated that treatment with an ARB, valsartan, attenuated vascular senescence and DNA damage and that the effects of valsartan were less in Agtr2 Ϫ mice, suggesting that both AT 2 receptor signaling and AT 1 receptor blockade are necessary for preventing vascular senescence. We, therefore, propose important beneficial pharmacotherapeutic effects of ARBs, by stimulating the AT 2 receptor, in the application of ARBs to age-related vascular disorders. 
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Expanded Methods
Cell culture
Vascular smooth muscle cells (VSMC) were isolated from the thoracic aorta of adult male wild-type (Agtr2 + ) mice (based on C57BL/6J strain; Clea Japan Inc., Osaka, Japan) and AT 2 receptor null (Agtr2 
Ultraviolet (UV) irradiation and hydrogen peroxide (H 2 O 2 ) treatment of VSMC
Cultures of VSMC (50-60% confluent) were subjected to repeated UV stress. VSMC were washed once with phosphate-buffered saline (PBS) and exposed to a subcytotoxic dose of UV radiation (250 mJ/cm 2 ) in a thin layer of PBS using a UV cross-linker (CL-1000, Funakoshi
Corp., Tokyo, Japan), followed by washing and replacement of growth medium. Irradiation was performed once a day for 5 days. 3 For hydrogen peroxide (H 2 O 2 ) treatment, 50-60% confluent VSMC were submitted to 2 hours' exposure to a subcytotoxic dose of H 2 O 2 (600 μmol/L) diluted in growth medium, followed by washing and replacement of growth medium. 4 After exposure to repeated UV irradiation for 5 days or H 2 O 2 for 2 hours, the cells were cultured under normal condition for 3 days and used for different experiments. Control cultures were performed in the same medium without UV or H 2 O 2 treatment.
Irradiated mouse model
This study was performed in accordance with the National Institutes of Health guidelines for the use of experimental animals. All animal studies were reviewed and approved by the Animal Studies Committee of Ehime University. Mice were maintained in a pathogen-free environment and exposed to a lethal dose, 10 Gy total-body X-ray irradiation at room temperature, using an irradiator (MBR-1520R-3, Hitachi, Tokyo, Japan). Valsartan was administered at a dose of 3 mg/kg/day i.p. via an osmotic minipump (Alzet model 1002, Durect Corporation) implanted 7 days before irradiation. The dose of valsartan we chose was a nonhypotensive dose and did not significantly influence blood pressure of mice. At 3 days after irradiation, the thoracic aorta was isolated.
Senescence-associated β-galactosidase (SA-β-gal) staining
Senescence-associated β-galactosidase (SA-β-gal) activity in VSMC cultured on 6-well plates was measured as previously described.
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The cells were counterstained with 4'6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA) for 10 minutes to count the numbers of total cells at ×20 magnification. Fresh thoracic aorta taken from mice were immediately trimmed of excess periadventitial tissue and opened vertically, and directly stained with SA-β-gal. Analysis of SA-β-gal activity in the aorta was performed using a computer-imaging software system (Densitograph, ATTO Corp., Tokyo, Japan).
Immunoblot analysis
Total proteins were prepared from VSMC cultured in 100-mm dishes and thoracic aorta under different experimental conditions. The proteins were subjected to SDS-PAGE and 
RNA interference of MMS2
For small interfering RNA (siRNA) assay, VSMC were transiently transfected with control siRNA or MMS2-specific siRNA, a cocktail of three siRNAs designed by B-Bridge (Sunnyvale, CA) as previously described.
2
Determination of NADPH oxidase activity in VSMC
Activity of NADPH oxidase in VSMC in total protein cell homogenates was measured by a luminescence assay as previously described, using 500 μmol/L lucigenin as the electron acceptor and 100 μmol/L NADPH as the substrate.
Detection of superoxide anion in VSMC
Superoxide generation of VSMC cultured on 6-well plates was evaluated using fluorogenic dihydroethidium (DHE, 5 μmol/L) as previously described. 2 Intensity of fluorescence was analyzed and quantified using computer-imaging software (Densitograph, ATTO Corp., Tokyo, Japan).
Quantification of 8-hydroxy-2'-deoxyguanosine (8-OHdG)
Immunoreactivity of 8-OHdG in DNA of VSMC and thoracic aorta of mice was detected by an enzyme-linked immunosorbent assay (ELISA). 
Ang II receptor binding assay
The changes in Ang II receptor densities in response to Ang II, UV radiation or H 2 O 2 were determined by radioligand binding assay as described previously. 
Materials
Reagents not listed above were as follows: An AT 1 receptor blocker, valsartan, was donated by Novartis Pharma AG (Basel, Switzerland). All other reagents not mentioned above were purchased from Sigma-Aldrich.
Statistical analysis
All values are expressed as mean±SEM in the text and figures. Data were evaluated by ANOVA followed by post-hoc analysis for multiple comparisons. Differences with P<0.05 were considered significant. 
